Lawsuits Over Urinary Incontinence Treatment Highlight Debate Over FDA Device Approval Process

The New York Times on Tuesday examined how recent lawsuits against the makers of ObTape, a vaginal sling for treating stress urinary incontinence, have raised questions about FDA’s processes for reviewing and clearing new medical devices. The device is a mesh-like sling that is inserted under the urethra.

More: continued here

Filed under: Medical Malpractice / Litigation on May 9th, 2009